Geoffrey M.D. Ling is Director of CATALYST BIOSCIENCES, INC.. Currently has a direct ownership of 31,790 shares of CBIO, which is worth approximately $0. The most recent transaction as insider was on Jan 07, 2022, when has been sold 12,855 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.8K
0% 3M change
0% 12M change
Total Value Held $0

Geoffrey M.D. Ling Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2022
BUY
Grant, award, or other acquisition
-
12,855 Added 28.79%
31,790 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
-
2,858 Added 13.11%
18,935 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
2,713 Added 14.44%
16,077 Common Stock
Apr 01 2021
BUY
Grant, award, or other acquisition
-
2,331 Added 14.85%
13,364 Common Stock
Jan 05 2021
BUY
Grant, award, or other acquisition
-
1,782 Added 13.91%
11,033 Common Stock
Oct 01 2020
BUY
Grant, award, or other acquisition
-
2,616 Added 22.04%
9,251 Common Stock

Also insider at

CELU
Celularity Inc Healthcare
GML

Geoffrey M.D. Ling

Director
South San Francisco, CA

Track Institutional and Insider Activities on CBIO

Follow CATALYST BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBIO shares.

Notify only if

Insider Trading

Get notified when an Catalyst Biosciences, Inc. insider buys or sells CBIO shares.

Notify only if

News

Receive news related to CATALYST BIOSCIENCES, INC.

Track Activities on CBIO